Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Zanni

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
Scientific Reports|July 8, 2022
Author Correction: Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIVAlexander G Bick, Konstantin Popadin, Christian W Thorball, et al.
The Journal of Clinical Endocrinology and Metabolism|December 12, 2025
Visceral adipose tissue and liver fat on 17-beta estradiol-dominant gender-affirming hormone therapy: A US-based cohortRia Talathi, Vencel Juhasz, Matilda Delgado, et al.
The Journal of Infectious Diseases|July 20, 2022
Increased Macrophage-Specific Arterial Infiltration Relates to Noncalcified Plaque and Systemic Immune Activation in People With Human Immunodeficiency VirusMabel Toribio, Moses Q Wilks, Sandeep Hedgire, et al.
AIDS (London, England)|June 26, 2026
Pitavastatin effect on enterocyte injury markers in an ART treated HIV population: Insights from REPRIEVEAya Awwad, Upasana Das Adhikari, Tricia H Burdo, et al.
Ebiomedicine|March 26, 2023
Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIVMárton Kolossváry, Chris deFilippi, Sara McCallum, et al.
Annals of Internal Medicine|October 7, 2024
Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention : A Randomized TrialKathleen V Fitch, Markella V Zanni, Jennifer Manne-Goehler, et al.
JACC. Advances|July 10, 2026
Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE TrialSteven K Grinspoon, Christopher DeFilippi, Triin Umbleja, et al.
The Journal of Infectious Diseases|May 18, 2019
Immune Correlates of Diffuse Myocardial Fibrosis and Diastolic Dysfunction Among Aging Women With Human Immunodeficiency VirusMarkella V Zanni, Magid Awadalla, Mabel Toribio, et al.
AIDS (London, England)|December 21, 2022
Plasma osteopontin relates to myocardial fibrosis and steatosis and to immune activation among women with HIVJake A Robinson, Mabel Toribio, Thiago Quinaglia, et al.
AIDS (London, England)|July 28, 2023
Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIVJordan E Lake, Jana Taron, Heather J Ribaudo, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Scientific Reports|July 8, 2022
Author Correction: Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIVAlexander G Bick, Konstantin Popadin, Christian W Thorball, et al.
The Journal of Clinical Endocrinology and Metabolism|December 12, 2025
Visceral adipose tissue and liver fat on 17-beta estradiol-dominant gender-affirming hormone therapy: A US-based cohortRia Talathi, Vencel Juhasz, Matilda Delgado, et al.
The Journal of Infectious Diseases|July 20, 2022
Increased Macrophage-Specific Arterial Infiltration Relates to Noncalcified Plaque and Systemic Immune Activation in People With Human Immunodeficiency VirusMabel Toribio, Moses Q Wilks, Sandeep Hedgire, et al.
AIDS (London, England)|June 26, 2026
Pitavastatin effect on enterocyte injury markers in an ART treated HIV population: Insights from REPRIEVEAya Awwad, Upasana Das Adhikari, Tricia H Burdo, et al.
Ebiomedicine|March 26, 2023
Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIVMárton Kolossváry, Chris deFilippi, Sara McCallum, et al.
Annals of Internal Medicine|October 7, 2024
Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention : A Randomized TrialKathleen V Fitch, Markella V Zanni, Jennifer Manne-Goehler, et al.
JACC. Advances|July 10, 2026
Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE TrialSteven K Grinspoon, Christopher DeFilippi, Triin Umbleja, et al.
The Journal of Infectious Diseases|May 18, 2019
Immune Correlates of Diffuse Myocardial Fibrosis and Diastolic Dysfunction Among Aging Women With Human Immunodeficiency VirusMarkella V Zanni, Magid Awadalla, Mabel Toribio, et al.
AIDS (London, England)|December 21, 2022
Plasma osteopontin relates to myocardial fibrosis and steatosis and to immune activation among women with HIVJake A Robinson, Mabel Toribio, Thiago Quinaglia, et al.
AIDS (London, England)|July 28, 2023
Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIVJordan E Lake, Jana Taron, Heather J Ribaudo, et al.
Pageof 15